AOTC
Phase 2- Indications
- Pain, Inflammation
Company intelligence / Profile preview
Panag Pharma Inc.
Halifax, Nova Scotia, Canadapanagrx.com ↗
- Ownership
- Private
- Development stage
- Phase 2
01
Overview
Developing plant-based remedies for pain management. Their product AWAYE™ is Health Canada approved with a Natural Product Number and was undergoing clinical trials as of 2019.
- Therapeutic areas
- NephrologyImmunologyDermatologyRheumatologyGastroenterologyOphthalmologyNeurologyInfectious Diseases
- Modalities
- Cannabinoid-based formulations
- Industry
- Biotech
02
Drug pipeline
1 assetBeyond the preview
Go deeper on Panag Pharma Inc..
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Panag Pharma Inc..